From: Predominance of triple wild-type and IGF2R mutations in mucosal melanomas
MM (n = 41) | CM (n = 48) | ||
---|---|---|---|
GENE | % | GENE | % |
IGF2R | 31.7 | FAT4 | 54.2 |
KMT2A | 22.0 | BRAF | 50.0 |
ATM | 17.1 | DCC | 41.7 |
NRAS | 17.1 | NRAS | 29.2 |
NF1 | 14.6 | KMT2A | 25.0 |
TET2 | 14.6 | ATM | 25.0 |
ACTL6A | 12.2 | NF1 | 20.8 |
APC | 12.2 | BRCA2 | 20.8 |
BRAF | 12.2 | MET | 20.8 |
BRCA2 | 12.2 | TSC2 | 18.8 |
DCC | 12.2 | ARID1A | 18.8 |
TSC2 | 12.2 | ATR | 18.8 |
FAT4 | 9.8 | MTOR | 18.8 |
KIT | 9.8 | EPHA3 | 18.8 |
LRP5 | 9.8 | FZD10 | 16.7 |
RET | 9.8 | TET2 | 14.6 |
TCF7L2 | 9.8 | APC | 14.6 |
 |  | LTK | 14.6 |